APLT - Applied Therapeutics reports additional 40mg/kg data from adult galactosemia study June, 15 2020 08:22 AM Applied Therapeutics Inc. Applied Therapeutics (NASDAQ:APLT) announces additional supportive biomarker efficacy and safety data for AT-007 in Galactosemia at 40 mg/kg.More news on: Applied Therapeutics, Inc., Healthcare stocks news, Read more ...